CVM · Cel-Sci Corp
United States · RS rating 20 · As of 2026-11-03
| Price | 1.41 USD |
|---|---|
| 1-day change | +7.6% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 6 / 51 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 16 / 20 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +1.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +81.6% |
| Market cap (USD) | $28.0M |